On April 4, 2024, the Food and Drug Administration conducted an inspection of the University of Illinois at Chicago In Vitro Fertilization Program located in Chicago, according to data posted on the FDA's website.

The inspection covered the following areas: • Blood and Blood Products • Human Cellular, Tissue, and Gene Therapies

The FDA's final report concluded that the University of Illinois at Chicago In Vitro Fertilization Program was not required to take any corrective actions regarding its management operations.

The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.

According to its

See Full Page